新型口服活性选择性β1肾上腺素能受体激动剂H 80/62在人体的血流动力学和耐受性研究 - Suppr

Suppr

超能文献

Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.

作者信息

Johnsson G, Jordö L, Lundborg P, Rönn O, Welin-Fogelberg I, Wikstrand J

出版信息

Eur J Clin Pharmacol. 1978 May 31;13(3):163-70. doi: 10.1007/BF00609978.

DOI:10.1007/BF00609978

PMID:27371

Abstract

摘要

相似文献

Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.新型口服活性选择性β1肾上腺素能受体激动剂H 80/62在人体的血流动力学和耐受性研究

Eur J Clin Pharmacol. 1978 May 31;13(3):163-70. doi: 10.1007/BF00609978.

Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors.一项关于新型口服活性心脏肾上腺素能β受体兴奋剂的人体药理学研究。

Am Heart J. 1978 May;95(5):602-10. doi: 10.1016/0002-8703(78)90302-2.

Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in man.新型选择性β1肾上腺素能受体激动剂普瑞特罗在人体中的血流动力学效应、药代动力学及其与美托洛尔的相互作用

Eur J Clin Pharmacol. 1979 Feb 19;15(1):9-13. doi: 10.1007/BF00563552.

The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.β-肾上腺素能受体部分激动剂奥昔非君长期口服给药的血流动力学效应：与普萘洛尔的比较。

Br J Pharmacol. 1974 May;51(1):5-13. doi: 10.1111/j.1476-5381.1974.tb09625.x.

[Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].[氧烯洛尔治疗缓慢性心律失常时人体心脏的刺激、刺激传导及心肌兴奋性（作者译）]

Med Klin. 1974 May 3;69(18):806-13.

[Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].β-肾上腺素能阻滞剂Kö 1366与心得宁对人体血流动力学影响的比较（作者译）

Arzneimittelforschung. 1975 Aug;25(8):1300-3.

Pharmacodynamic studies in man of the beta-adrenoceptor antagonist DL 071 IT.β-肾上腺素能受体拮抗剂DL 071 IT在人体的药效学研究。

Eur J Clin Pharmacol. 1979 Sep;16(2):87-90. doi: 10.1007/BF00563112.

Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.口服普瑞特罗对人体的血流动力学影响、血浆浓度及耐受性

Eur J Clin Pharmacol. 1980 Nov;18(5):383-90. doi: 10.1007/BF00636789.

[Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].新型β受体阻断剂他林洛尔（Cordanum，02-115）对人体的血流动力学作用

Pharmazie. 1975 Oct;30(10):678-81.

Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.新型β-肾上腺素能受体拮抗剂倍他洛尔（SL 75212）口服和静脉给药后的血药浓度及药效学效应

Br J Clin Pharmacol. 1980 Nov;10(5):449-52. doi: 10.1111/j.1365-2125.1980.tb01787.x.

引用本文的文献

The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.通过放射性核素心室造影评估静脉注射普瑞特罗对缺血性心脏病患者心室功能的影响。

Br J Clin Pharmacol. 1981 Oct;12(4):475-80. doi: 10.1111/j.1365-2125.1981.tb01253.x.

Short- and long-term effects of hydralazine and combined hydralazine-prenalterol therapy in severe chronic congestive heart failure.肼屈嗪及肼屈嗪与普萘洛尔联合治疗对重度慢性充血性心力衰竭的短期及长期影响

Klin Wochenschr. 1981 Jun 15;59(12):647-54. doi: 10.1007/BF02593856.

Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failure.对充血性心力衰竭患者单次及多次服用控释片后普瑞特罗的药代动力学研究。

Eur J Clin Pharmacol. 1983;24(4):495-502. doi: 10.1007/BF00609892.

Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure.普瑞特罗，一种口服β-1肾上腺素能受体激动剂，用于治疗慢性心力衰竭。

Eur J Clin Pharmacol. 1983;25(4):539-45. doi: 10.1007/BF00542125.

Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.普瑞特罗对慢性肾衰竭患者心脏功能及透壁心肌灌注的影响。

Eur J Clin Pharmacol. 1983;25(3):287-92. doi: 10.1007/BF01037935.

Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.对慢性重症心力衰竭患者进行β1 激动剂普瑞特罗的急性静脉注射和持续口服治疗。

Br Heart J. 1984 May;51(5):530-8. doi: 10.1136/hrt.51.5.530.

Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.普瑞特罗（一种具有正性肌力和降低阻力作用的β-肾上腺素能激动剂）在正常受试者中的剂量-反应关系。

Eur J Clin Pharmacol. 1984;27(5):539-43. doi: 10.1007/BF00556889.

Lack of effect of prenalterol on dialysis-associated hypotension.普瑞特罗对透析相关性低血压无效。

Eur J Clin Pharmacol. 1984;26(3):399-400. doi: 10.1007/BF00548774.

Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.普瑞特罗对慢性充血性心力衰竭患者静息和运动血流动力学的心血管效应。

Br Heart J. 1982 Apr;47(4):375-80. doi: 10.1136/hrt.47.4.375.

Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterol.选择性β1肾上腺素能受体激动剂普瑞特罗在人体的药代动力学研究。

Eur J Clin Pharmacol. 1981;20(2):91-7. doi: 10.1007/BF00607143.

本文引用的文献

THE EFFECT OF DESLANOSIDE ON THE DURATION OF THE PHASES OF VENTRICULAR SYSTOLE IN MAN.去乙酰毛花苷对人体心室收缩各期时长的影响。

Am J Cardiol. 1965 Feb;15:153-61. doi: 10.1016/0002-9149(65)90449-2.

Bedside technics for the evaluation of ventricular function in man.人体心室功能评估的床边技术。

Am J Cardiol. 1969 Apr;23(4):577-83. doi: 10.1016/0002-9149(69)90012-5.

In vivo analysis of adrenergic receptor activity of dobutamine.多巴酚丁胺肾上腺素能受体活性的体内分析。

Circ Res. 1974 May;34(5):663-71. doi: 10.1161/01.res.34.5.663.

Systolic time intervals as measures of the contractile state of the left ventricular myocardium in man.收缩期时间间期作为衡量人体左心室心肌收缩状态的指标。

Circulation. 1972 Sep;46(3):559-71. doi: 10.1161/01.cir.46.3.559.

Absorption of alprenolol in man from tablets with different rates of release.不同释放速率的阿普洛尔片剂在人体中的吸收情况。

Acta Pharm Suec. 1971 Mar;8(1):59-70.

Recent beta-adrenoreceptor stimulants.近期的β-肾上腺素能受体兴奋剂。

Adv Drug Res. 1970;5:197-253.

A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline.沙丁胺醇、奥西那林和索特诺尔与异丙肾上腺素的β-肾上腺素能受体兴奋特性比较。

J Pharm Pharmacol. 1970 Dec;22(12):945-7. doi: 10.1111/j.2042-7158.1970.tb08481.x.

Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work.美托洛尔和普萘洛尔对肾上腺素及体力活动所致血流动力学效应的影响。

Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):59-68. doi: 10.1111/j.1600-0773.1975.tb03322.x.

Distortion of non-invasive cardiac pulse curves. A capillary-damped pick-up and a calibration unit forapex cardiograms and other pulse curves.无创心脏脉搏曲线的失真。一种用于心尖心动图和其他脉搏曲线的毛细管阻尼传感器及校准单元。

Br Heart J. 1977 Sep;39(9):995-1005. doi: 10.1136/hrt.39.9.995.

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.多巴酚丁胺：一种新型儿茶酚胺的研发，用于选择性增强心肌收缩力。

Circ Res. 1975 Jan;36(1):185-96. doi: 10.1161/01.res.36.1.185.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验